Page 49 - Eric Domingo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Infectious diseases expert warns of Ivermectin health risks enablePagination: false endIndex: Metro Manila (CNN Philippines, April 6) — Infectious diseases expert Dr. Rontgene Solante on Tuesday said repurposing anti-parasitic drug Ivermectin could result in "detrimental effects" in humans. At present, Ivermectin is only approved for veterinary use to prevent heartworm disease in animals. It is also used to treat parasite infestation such as head lice and scabies. Several lawmakers and businessmen, however, have been pushing the government to consider repurposing the drug to prevent and tr...

By ANNA FELICIA BAJO, GMA News Published April 6, 2021 12:40pm "May consent naman 'yung tao doon eh (People give consent on using it)." This was the response of Anakalusugan party-list Representative Mike Defensor when asked on who will be held liable in case there will be adverse side effects after using anti-parasitic drug ivermectin as anti-virus medicine. Defensor has been pushing for the use of ivermectin as a possible treatment against COVID-19 even if the drug is still unauthorized for human use. "The point is before you get the prescription, before you are allowed to take it, ...

American pharmaceutical firm Johnson & Johnson has applied for an emergency use authorization (EUA) of its single-dose vaccine against coronavirus disease (COVID-19) in the Philippines, the Food and Drug Administration (FDA) confirmed Monday, April 5.

Johnson & Johnson files for vaccine emergency use in PH Updated Apr 5, 2021 3:17:00 PM enablePagination: false Johnson & Johnson has applied for emergency use of its single-dose COVID-19 vaccine in the Philippines. Metro Manila (CNN Philippines, April 5) — US drugmaker Johnson & Johnson has applied for emergency use of its single-dose COVID-19 vaccine in the Philippines, Food and Drug Administration Director General Eric Domingo confirmed to CNN Philippines on Monday. The vaccine, made by Belgium-based firm Janssen Pharmaceuticals, J&J's vaccine arm, was already authorized last month by t...

(Photo by ERNESTO BENAVIDES / AFP / FILE PHOTO) “The DOH and the FDA would like to clarify that Lianhua Qingwen is a prescription medicine approved by FDA in the Philippines but is not registered as a COVID-19 medication,” the agencies said in a statement. “Any food or medicinal products not registered in the Philippines should not be sold and are subject to seizure or confiscation hence the FDA issued Advisory No. 2020-767 before the registration of Lianhua Qingwen,” they added. The DOH and the FDA said it was only on Aug. 7, 2020 that Lianhua Qingwen was able to acquire FDA registra...